-
IMV Inc. (IMV $1.12)
- $1.12 Cap: $13M
- View IMV Profile
- View Questions on IMV
Detailed Quote
Questions on this company?
Become a Member
Company Profile
{tplLang.businessdescription | toLang tLang}
{ profileData.description }
{tplLang.details | toLang tLang}
{tplLang.ceo | toLang tLang}
{profileData.profile.details.ceo}
{tplLang.employees | toLang tLang}
{profileData.profile.details.employees | numeraljs '0,0'}
{tplLang.issuetype | toLang tLang}
{profileData.profile.details.issuetype | asIssueType}
{tplLang.industryclassifications | toLang tLang}
{tplLang.sector | toLang tLang}
{profileData.profile.classification.sector}
{tplLang.industry | toLang tLang}
{profileData.profile.classification.industry}
{tplLang.toolname| toLang tLang}
There is no {tplLang.toolname| toLang tLang} currently available for
{data.symbolstring}.
Interactive Chart
Key Ratios
Earnings
Analyst Recommendations
5i Recent Questions
-
IMV Inc. (IMV $1.12)
- $1.12 Cap: $13M
- View IMV Profile
- View Questions on IMV
Q: Hi Team, IMV 3rd quarter 2020 results and clinical update is good ?and worth to gamble on this company ?
Thanks as always,
Tak
Thanks as always,
Tak
-
IMV Inc. (IMV $1.12)
- $1.12 Cap: $13M
- View IMV Profile
- View Questions on IMV
Q: Is there a potentially worthwhile option in the Canadian market for a company that's working on a vaccine, even indirectly?
-
Regeneron Pharmaceuticals Inc. (REGN $545.53)
- $545.53 P/E (TTM): 13.79X Cap: $58.57B
- View REGN Profile
- View Questions on REGN
-
Pfizer Inc. (PFE $24.26)
- $24.26 P/E (TTM): 17.73X Cap: $137.92B
- View PFE Profile
- View Questions on PFE
-
IMV Inc. (IMV $1.12)
- $1.12 Cap: $13M
- View IMV Profile
- View Questions on IMV
-
Inovio Pharmaceuticals Inc. (INO $1.42)
- $1.42 Cap: $50M
- View INO Profile
- View Questions on INO
-
Novavax Inc. (NVAX $7.17)
- $7.17 P/E (TTM): 2.55X Cap: $1.13B
- View NVAX Profile
- View Questions on NVAX
-
Moderna Inc. (MRNA $30.97)
- $30.97 Cap: $12.08B
- View MRNA Profile
- View Questions on MRNA
-
BioNTech SE (BNTX $108.91)
- $108.91 Cap: $26.40B
- View BNTX Profile
- View Questions on BNTX
Q: Is there a Canadian company that you would recommend that possibly would benefit from a vaccine to overcome Covid 19, if not what U.S. or international company would you recommend? Thank You.
Insiders
Share Information
News and Media